Cargando…

Fatty liver diseases, bile acids, and FXR

The prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide has increased at an alarming rate, which will likely result in enormous medical and economic burden. NAFLD presents as a spectrum of liver diseases ranging from simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yan, Liu, Hongxia, Zhang, Min, Guo, Grace L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045552/ https://www.ncbi.nlm.nih.gov/pubmed/27709009 http://dx.doi.org/10.1016/j.apsb.2016.07.008

Ejemplares similares

Bile Acids and FXR: Novel Targets for Liver Diseases
por: Stofan, Mary, et al.
Publicado: (2020)

Impact of bile acids on the growth of human cholangiocarcinoma via FXR
por: Dai, Jiaqi, et al.
Publicado: (2011)

Bile acid nuclear receptor FXR and digestive system diseases
por: Ding, Lili, et al.
Publicado: (2015)

Deciphering the nuclear bile acid receptor FXR paradigm
por: Modica, Salvatore, et al.
Publicado: (2010)

Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
por: Xiang, Junwei, et al.
Publicado: (2021)

Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery
por: Noel, Olivier F., et al.
Publicado: (2016)

Proteomics for the discovery of nuclear bile acid receptor FXR targets()
por: Gardmo, Cissi, et al.
Publicado: (2011)

Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis
por: Katafuchi, Takeshi, et al.
Publicado: (2022)

Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
por: Wilson, Aze, et al.
Publicado: (2020)

Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
por: Byun, Sangwon, et al.
Publicado: (2018)

Optical control of the nuclear bile acid receptor FXR with a photohormone
por: Morstein, Johannes, et al.
Publicado: (2019)

Bile Acids, Microbiota, and Cystic Fibrosis: Channeling Intestinal FXR Signals
por: McHenry, Scott, et al.
Publicado: (2019)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
por: Wang, Caihua, et al.
Publicado: (2019)

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
por: Jadhav, Kavita, et al.
Publicado: (2018)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis
por: Dai, Yihang, et al.
Publicado: (2023)

Bile acids and sphingolipids in non-alcoholic fatty liver disease
por: Jackson, Kaitlyn G., et al.
Publicado: (2022)

Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism
por: Kumari, Anita, et al.
Publicado: (2020)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
por: Ye, Xin, et al.
Publicado: (2022)

Bile acid-FXRα pathways regulate male sexual maturation in mice
por: Baptissart, Marine, et al.
Publicado: (2016)

The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis
por: Zhou, Xiaodong, et al.
Publicado: (2017)

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
por: Gomez-Ospina, Natalia, et al.
Publicado: (2016)

Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5
por: Trammell, Samuel A. J., et al.
Publicado: (2020)

FXR deficiency in hepatocytes disrupts the bile acid homeostasis and inhibits autophagy to promote liver injury in Schistosoma japonicum-infected mice
por: Zhang, Beibei, et al.
Publicado: (2022)

FXR and NASH: an avenue for tissue-specific regulation
por: Henry, Zakiyah, et al.
Publicado: (2023)

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
por: Zhang, Dan-Ying, et al.
Publicado: (2019)

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
por: Baars, Annemarie, et al.
Publicado: (2015)

Fxr signaling and microbial metabolism of bile salts in the zebrafish intestine
por: Wen, Jia, et al.
Publicado: (2021)

Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
por: Jin, Lihua, et al.
Publicado: (2015)

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)

Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models
por: Zhang, Yuanyuan, et al.
Publicado: (2017)

Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands
por: Finamore, Claudia, et al.
Publicado: (2016)

Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro
por: De Gottardi, Andrea, et al.
Publicado: (2006)

Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
por: Radun, Richard, et al.
Publicado: (2021)

Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Miyata, Sachiho, et al.
Publicado: (2021)

Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
por: Correia, Jorge C., et al.
Publicado: (2015)

Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling
por: Ren, Zi-Lin, et al.
Publicado: (2022)

Upregulation of Taurine Biosynthesis and Bile Acid Conjugation with Taurine through FXR in a Mouse Model with Human-like Bile Acid Composition
por: Miyazaki, Teruo, et al.
Publicado: (2023)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Role of FXR in Renal Physiology and Kidney Diseases
por: Guo, Yanlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvrfps23b9tr5hf4og4dib60hq